Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.60    0.10 (0.27%)
Bid:
36.50
Ask:
36.70
Spread: 0.20 (0.548%)
Market Cap: £26.87m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

26 Sep 2025 07:00

RNS Number : 9094A
Carclo plc
26 September 2025
Ā 

26 September 2025

Carclo plc

Trading Update

Ā 

Carclo plc ("Carclo" or the "Group"), is pleased to announce the following trading update ahead of the AGM to be held later today.

Group Financial Performance

The Group's trading performance year to date is in line with management's expectations, with strong margin performance and positive underlying growth, excluding the effect of exchange rate movements, in both CTP Manufacturing Solutions and our Speciality business.

This robust operational delivery offsets the lower Design and Engineering ("D&E") revenue and foreign exchange headwinds arising from a strengthening sterling since the beginning of the year. This has resulted in slightly lower than anticipated revenues but maintaining our expected overall performance.

Operating cashflow year to date is in line with management's expectations with net debt increasing from the year-end position largely driven by the £5.1m payment into the defined benefit pension scheme in April 2025. The business has maintained tight capital discipline in both capital expenditure and working capital which remains toward the lower end of the target range of 5% to 7.5% of sales.

Outlook

The Board's expectations for the full year performance remain unchanged with D&E revenues expected to partially recover in the second half and the strong margin performance anticipated to be maintained through the year.

CTP Manufacturing Solutions

The strategic realignment of the CTP Manufacturing Solutions portfolio was completed in the first half of the prior financial year with the final exits of the non-core short-run product lines in September 2024. The business is now focused on delivering consistent operational performance following this portfolio restructuring.

The consolidation of the US operations into Pennsylvania is bearing fruit, with the new management team and specialised production cells delivering improved operational performance and resource utilisation. As a result, the US business is demonstrating both underlying sales growth, before the effect of currency translation, and stronger margins delivering significantly improved financial performance compared to prior year.

The EMEA operations continue to perform strongly, with both steady top line growth compared to prior year and solid margin performance as the strategy to focus the UK operations on high volume, highly automated solutions with more flexible, medium volume runs in our Czechia facility. In Asia Pacific, our China operations have performed ahead of management's expectations in both sales and margin delivery, whilst India has experienced below-forecast sales performance due to lower demand from a key customer. We have secured significant new business in India which should enable the shortfall to be recovered in the second half.

CTP Design and Engineering

Overall CTP D&E revenue year to date was below both expectation and prior year run-rate due to lower customer activity in the US, with EMEA D&E customer project activity ahead of expectation and prior year. The D&E team continues to maintain its focus on asset revitalisation and driving efficiency improvements in our global manufacturing platform which remains critical to delivering our medium-term financial goals.

Ā 

Speciality

The Speciality business continues to grow strongly, with robust demand from the aerospace sector coupled with market share gains in specialist machining delivering double digit revenue growth. The focus on operational performance and delivery, coupled with specialist, niche offerings enabled the business to maintain strong margins. We have invested in additional capacity to support this growth trajectory, with our first new CNC machine now operational at our French facility.

Enquiries:

Carclo plc +44 (0) 20 8685 0500

Frank Doorenbosch, Chief Executive Officer

Ian Tichias, Chief Financial Officer

Ā 

Panmure Liberum (Corporate Broker) +44 (0) 20 3100 2000

Amrit Mahbubani

Mark Murphy

Ā 

About Carclo plc:

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. Carclo is a global precision engineering group that designs, industrialises and manufactures highly-reliable solutions for Life Sciences, Aerospace and Safety & Security markets, manufactured in-region, for-region.Ā 

LEI: 21380078MEM399JPI956

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
TSTVELFLEKLFBBZ
Date   Source Headline
29th Apr 20264:59 pmRNSDirector Dealing – Late Notification
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 202610:34 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Update
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSHalf-year Financial Report
17th Nov 20257:00 amRNSNotice of Half Year Results
30th Sep 20256:20 pmRNSDirector/PDMR Shareholding
30th Sep 20256:14 pmRNSDirector/PDMR Shareholding
26th Sep 202512:30 pmRNSResult of AGM
26th Sep 20257:00 amRNSTrading Update
19th Sep 20255:58 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSChange of Auditor
11th Sep 20258:41 amRNSDirector/PDMR Shareholding
1st Sep 20257:30 amRNSRestoration - Carclo PLC
29th Aug 202511:55 amRNSNotice of AGM
29th Aug 20257:00 amRNSFull Year 2025 audited results
28th Aug 20257:00 amRNSNotice of Results and Investor Presentation
1st Aug 20257:30 amRNSSuspension - Carclo PLC
17th Jul 20254:42 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSContract renewal strengthens revenue visibility
10th Jul 20257:00 amRNSTrading Statement & Delay in 2025 Audited Results
2nd May 202511:33 amRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Statement
28th Apr 20255:06 pmRNSHolding(s) in Company
24th Apr 20254:02 pmRNSRefinancing Arrangements, Pension Scheme Valuation
3rd Apr 20257:00 amRNSHolding(s) in Company
6th Mar 202510:43 amRNSHolding(s) in Company
18th Feb 20255:10 pmRNSHolding(s) in Company
13th Feb 20257:00 amRNSCFO Appointment
19th Dec 20243:49 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSInterim Report and Accounts 30 September 2024
12th Nov 202411:11 amRNSNotice of Interim Results & Investor Presentation
10th Sep 20249:33 amRNSHolding(s) in Company
5th Sep 20241:30 pmRNSResult of AGM
5th Sep 20247:00 amRNSTrading Update
16th Aug 202412:32 pmRNSHolding(s) in Company
5th Aug 202412:11 pmRNSHolding(s) in Company
31st Jul 202410:00 amRNS2024 Annual Report & Accounts and Notice of AGM
30th Jul 20243:21 pmRNSHolding(s) in Company
24th Jul 20242:49 pmRNSHolding(s) in Company
24th Jul 202412:57 pmRNSHolding(s) in Company
23rd Jul 20243:48 pmRNSHolding(s) in Company
23rd Jul 20241:08 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSFinal Results
17th Jul 20241:07 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSNotice of Results
8th Jul 20248:51 amRNSBank Facilities Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.